Skip to main content
. 2011 Jul 25;29(25):3381–3388. doi: 10.1200/JCO.2010.34.3426

Fig 2.

Fig 2.

Overall survival by chemotherapy administration status and stage group (Kaplan-Meier) with propensity score weighting. Cox regression–based test for equality of survival curves: (A) stage II with no poor prognostic features: Wald χ2 = 0.01, P = .94; (B) stage II with any poor prognostic features: Wald χ2 = 0.20, P = .65; (C) stage III: Wald χ2 = 232.80, P < .001.

HHS Vulnerability Disclosure